China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	186	34	1	3	11	29
Market Cap Growth	3514.19%	3514.19%	-67.93%	-73.95%	-60.15%	83.78%
Enterprise Value	170	26	-7	2	14	19
Last Close Price	1.61	2.49	13.44	56.72	1120.00	7360.00
PS Ratio	1.32	19.72	0.49	1.50	4.37	5.97
PB Ratio	1.44	2.22	0.07	0.20	0.69	1.79
P/TBV Ratio	12.11	2.23	0.07	0.20	0.69	1.79
P/FCF Ratio	-	-	-	-	55.27	-
P/OCF Ratio	-	-	-	-	42.40	-
EV/Sales Ratio	97.39	14.76	-	0.79	5.37	3.93
EV/FCF Ratio	-	-	-	-	67.88	-
Debt / Equity Ratio	0.06	0.06	0.27	0.61	0.65	0.76
Debt / FCF Ratio	-	-	-	-	52.20	-
Asset Turnover	0.08	0.08	0.07	0.06	0.08	0.17
Inventory Turnover	1.42	1.42	1.98	1.88	1.10	1.60
Quick Ratio	3.33	3.33	1.51	1.31	1.14	1.00
Current Ratio	3.54	3.54	1.60	1.35	1.31	1.25
Return on Equity (ROE)	-22.50%	-22.50%	-21.65%	-38.15%	-35.42%	-21.67%
Return on Assets (ROA)	-7.48%	-7.48%	-4.96%	-10.42%	-9.53%	-4.88%
Return on Capital (ROIC)	-9.84%	-9.84%	-6.34%	-12.93%	-11.73%	-6.20%
Earnings Yield	-1.77%	-9.62%	-326.13%	-200.33%	-50.43%	-9.63%
FCF Yield	-1.26%	-6.84%	-203.68%	-5.11%	1.81%	-4.94%
Buyback Yield / Dilution	-1212.67%	-1212.67%	-224.91%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q